In vitro assays were carried out in MDA-MB-231 cells with GLYAT knockdown (KD) and overexpression (OE) in MCF-7 cells to determine the impact of GLYAT expression on breast cancer behavior (Figures 2B, C). Here, GLYAT is linked to breast cancer.